Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in MLL-rearranged infant ALL

• Matthias Wölfl,
• Mareike Rasche,
• Matthias Eyrich,
• Renate Schmid,
• Dirk Reinhardt,
• Paul G. Schlegel

Affiliations

Matthias Wölfl

Pediatric Hematology, Oncology and Stem Cell Transplantation, Children's Hospital, University of Würzburg, Würzburg, Germany;; Matthias Wölfl, University Children's Hospital, Department of Pediatric Oncology, Hematology and Stem Cell Transplantation, Josef-Schneider-Str 2, 97080 Würzburg, Germany;

Mareike Rasche

Department of Pediatric Hematology/Oncology, Pediatrics III, University Hospital of Essen, Essen, Germany

Matthias Eyrich

Pediatric Hematology, Oncology and Stem Cell Transplantation, Children's Hospital, University of Würzburg, Würzburg, Germany;

Renate Schmid

Pediatric Hematology, Oncology and Stem Cell Transplantation, Children's Hospital, University of Würzburg, Würzburg, Germany;

Dirk Reinhardt

Department of Pediatric Hematology/Oncology, Pediatrics III, University Hospital of Essen, Essen, Germany

Paul G. Schlegel

Pediatric Hematology, Oncology and Stem Cell Transplantation, Children's Hospital, University of Würzburg, Würzburg, Germany;